EW logo

Edwards Lifesciences (EW) EBITDA

annual EBITDA:

$1.48B-$280.50M(-15.93%)
December 31, 2024

Summary

  • As of today (June 22, 2025), EW annual EBITDA is $1.48 billion, with the most recent change of -$280.50 million (-15.93%) on December 31, 2024.
  • During the last 3 years, EW annual EBITDA has fallen by -$375.10 million (-20.22%).
  • EW annual EBITDA is now -23.16% below its all-time high of $1.93 billion, reached on December 31, 2022.

Performance

EW EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

quarterly EBITDA:

$409.90M-$73.80M(-15.26%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW quarterly EBITDA is $409.90 million, with the most recent change of -$73.80 million (-15.26%) on March 1, 2025.
  • Over the past year, EW quarterly EBITDA has dropped by -$66.30 million (-13.92%).
  • EW quarterly EBITDA is now -51.04% below its all-time high of $837.20 million, reached on December 31, 2014.

Performance

EW quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

TTM EBITDA:

$1.74B-$66.30M(-3.67%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW TTM EBITDA is $1.74 billion, with the most recent change of -$66.30 million (-3.67%) on March 1, 2025.
  • Over the past year, EW TTM EBITDA has increased by +$140.20 million (+8.77%).
  • EW TTM EBITDA is now -11.99% below its all-time high of $1.98 billion, reached on September 30, 2022.

Performance

EW TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EW EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.9%-13.9%+8.8%
3 y3 years-20.2%-14.2%-9.2%
5 y5 years+15.9%+4.3%+29.9%

EW EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.2%at low-16.3%+76.6%-12.0%+14.0%
5 y5-year-23.2%+42.4%-22.7%+4125.8%-12.0%+67.3%
alltimeall time-23.2%+1725.0%-51.0%+1229.2%-12.0%+3680.9%

EW EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$409.90M(-15.3%)
$1.74B(-3.7%)
Dec 2024
$1.48B(-15.9%)
$483.70M(+12.8%)
$1.81B(+11.5%)
Sep 2024
-
$428.80M(+2.9%)
$1.62B(+1.5%)
Jun 2024
-
$416.80M(-12.5%)
$1.60B(-0.2%)
Mar 2024
-
$476.20M(+60.2%)
$1.60B(+0.5%)
Dec 2023
$1.76B(-8.6%)
$297.20M(-26.6%)
$1.59B(+4.3%)
Sep 2023
-
$405.00M(-3.7%)
$1.53B(-5.3%)
Jun 2023
-
$420.60M(-10.1%)
$1.61B(-3.5%)
Mar 2023
-
$467.80M(+101.6%)
$1.67B(-0.6%)
Dec 2022
$1.93B(+3.8%)
$232.10M(-52.6%)
$1.68B(-15.1%)
Sep 2022
-
$489.70M(+2.3%)
$1.98B(+3.1%)
Jun 2022
-
$478.80M(+0.2%)
$1.92B(+0.1%)
Mar 2022
-
$477.70M(-9.9%)
$1.92B(+3.2%)
Dec 2021
$1.86B(+78.4%)
$530.00M(+23.3%)
$1.86B(+39.0%)
Sep 2021
-
$429.70M(-10.0%)
$1.33B(+3.6%)
Jun 2021
-
$477.70M(+14.3%)
$1.29B(+21.0%)
Mar 2021
-
$417.80M(+4207.2%)
$1.06B(+2.4%)
Dec 2020
$1.04B(-18.6%)
$9.70M(-97.5%)
$1.04B(-22.9%)
Sep 2020
-
$382.80M(+50.5%)
$1.35B(+4.6%)
Jun 2020
-
$254.30M(-35.3%)
$1.29B(-3.7%)
Mar 2020
-
$392.90M(+23.1%)
$1.34B(+4.9%)
Dec 2019
$1.28B(+46.9%)
$319.20M(-1.2%)
$1.28B(+29.3%)
Sep 2019
-
$323.00M(+6.2%)
$987.60M(+5.7%)
Jun 2019
-
$304.20M(-7.8%)
$934.20M(+1.8%)
Mar 2019
-
$330.10M(+989.4%)
$917.70M(+5.6%)
Dec 2018
$868.70M(-23.8%)
$30.30M(-88.8%)
$868.70M(-23.5%)
Sep 2018
-
$269.60M(-6.3%)
$1.14B(+2.5%)
Jun 2018
-
$287.70M(+2.3%)
$1.11B(+1.6%)
Mar 2018
-
$281.10M(-5.4%)
$1.09B(-4.4%)
Dec 2017
$1.14B(+37.6%)
$297.20M(+23.1%)
$1.14B(+9.6%)
Sep 2017
-
$241.40M(-10.8%)
$1.04B(+2.7%)
Jun 2017
-
$270.70M(-18.1%)
$1.01B(+7.6%)
Mar 2017
-
$330.70M(+67.6%)
$940.60M(+13.6%)
Dec 2016
$828.30M(+17.4%)
$197.30M(-7.6%)
$828.30M(+1.4%)
Sep 2016
-
$213.60M(+7.3%)
$817.10M(+5.1%)
Jun 2016
-
$199.00M(-8.9%)
$777.80M(+4.8%)
Mar 2016
-
$218.40M(+17.4%)
$742.40M(+5.2%)
Dec 2015
$705.40M(-42.6%)
$186.10M(+6.8%)
$705.40M(-48.0%)
Sep 2015
-
$174.30M(+6.5%)
$1.36B(+2.0%)
Jun 2015
-
$163.60M(-9.8%)
$1.33B(+2.2%)
Mar 2015
-
$181.40M(-78.3%)
$1.30B(+5.8%)
Dec 2014
$1.23B(+110.6%)
$837.20M(+467.6%)
$1.23B(+110.2%)
Sep 2014
-
$147.50M(+8.9%)
$585.20M(+4.5%)
Jun 2014
-
$135.40M(+23.4%)
$560.20M(-1.0%)
Mar 2014
-
$109.70M(-43.0%)
$566.00M(-3.1%)
Dec 2013
$583.90M(+30.8%)
$192.60M(+57.2%)
$583.90M(+11.6%)
Sep 2013
-
$122.50M(-13.2%)
$523.30M(+2.7%)
Jun 2013
-
$141.20M(+10.7%)
$509.50M(+7.6%)
Mar 2013
-
$127.60M(-3.3%)
$473.40M(+6.2%)
Dec 2012
$446.30M
$132.00M(+21.4%)
$445.70M(+12.0%)
Sep 2012
-
$108.70M(+3.4%)
$398.00M(+10.0%)
DateAnnualQuarterlyTTM
Jun 2012
-
$105.10M(+5.2%)
$361.80M(+4.9%)
Mar 2012
-
$99.90M(+18.5%)
$345.00M(+0.1%)
Dec 2011
$344.70M(+5.4%)
$84.30M(+16.3%)
$344.70M(-0.5%)
Sep 2011
-
$72.50M(-17.9%)
$346.40M(-2.2%)
Jun 2011
-
$88.30M(-11.3%)
$354.20M(+2.2%)
Mar 2011
-
$99.60M(+15.8%)
$346.70M(+6.1%)
Dec 2010
$327.10M(-10.6%)
$86.00M(+7.1%)
$326.90M(+2.8%)
Sep 2010
-
$80.30M(-0.6%)
$318.00M(-8.7%)
Jun 2010
-
$80.80M(+1.3%)
$348.20M(+0.8%)
Mar 2010
-
$79.80M(+3.5%)
$345.60M(-5.5%)
Dec 2009
$365.80M(+61.0%)
$77.10M(-30.2%)
$365.80M(+10.4%)
Sep 2009
-
$110.50M(+41.3%)
$331.20M(+18.8%)
Jun 2009
-
$78.20M(-21.8%)
$278.80M(+3.8%)
Mar 2009
-
$100.00M(+135.3%)
$268.60M(+22.7%)
Dec 2008
$227.20M(-0.1%)
$42.50M(-26.9%)
$218.90M(-7.0%)
Sep 2008
-
$58.10M(-14.6%)
$235.50M(+3.3%)
Jun 2008
-
$68.00M(+35.2%)
$228.00M(+3.3%)
Mar 2008
-
$50.30M(-14.9%)
$220.80M(-3.4%)
Dec 2007
$227.40M(-1.1%)
$59.10M(+16.8%)
$228.50M(+0.6%)
Sep 2007
-
$50.60M(-16.8%)
$227.10M(-1.5%)
Jun 2007
-
$60.80M(+4.8%)
$230.50M(+0.4%)
Mar 2007
-
$58.00M(+0.5%)
$229.60M(-8.8%)
Dec 2006
$230.00M(-0.6%)
$57.70M(+6.9%)
$251.80M(-1.4%)
Sep 2006
-
$54.00M(-9.8%)
$255.40M(-0.0%)
Jun 2006
-
$59.90M(-25.3%)
$255.50M(-0.1%)
Mar 2006
-
$80.20M(+30.8%)
$255.80M(+10.4%)
Dec 2005
$231.50M(+10.2%)
$61.30M(+13.3%)
$231.80M(+3.1%)
Sep 2005
-
$54.10M(-10.1%)
$224.90M(+1.6%)
Jun 2005
-
$60.20M(+7.1%)
$221.40M(+3.1%)
Mar 2005
-
$56.20M(+3.3%)
$214.80M(+10.3%)
Dec 2004
$210.10M(+14.2%)
$54.40M(+7.5%)
$194.70M(+1.9%)
Sep 2004
-
$50.60M(-5.6%)
$191.00M(+3.7%)
Jun 2004
-
$53.60M(+48.5%)
$184.20M(+6.5%)
Mar 2004
-
$36.10M(-28.8%)
$173.00M(-4.3%)
Dec 2003
$184.00M(+98.9%)
$50.70M(+15.8%)
$180.70M(+5.1%)
Sep 2003
-
$43.80M(+3.3%)
$172.00M(+76.6%)
Jun 2003
-
$42.40M(-3.2%)
$97.40M(+1.8%)
Mar 2003
-
$43.80M(+4.3%)
$95.70M(+3.5%)
Dec 2002
$92.50M(+14.1%)
$42.00M(-236.4%)
$92.50M(+2.5%)
Sep 2002
-
-$30.80M(-175.7%)
$90.20M(-42.0%)
Jun 2002
-
$40.70M(+0.2%)
$155.40M(+98.2%)
Mar 2002
-
$40.60M(+2.3%)
$78.40M(-3.3%)
Dec 2001
$81.10M(-52.0%)
$39.70M(+15.4%)
$81.10M(-20.5%)
Sep 2001
-
$34.40M(-194.8%)
$102.00M(-4.9%)
Jun 2001
-
-$36.30M(-183.8%)
$107.30M(-38.5%)
Mar 2001
-
$43.30M(-28.5%)
$174.60M(-1.5%)
Dec 2000
$169.00M(-15.9%)
$60.60M(+52.6%)
$177.30M(+51.9%)
Sep 2000
-
$39.70M(+28.1%)
$116.70M(+51.6%)
Jun 2000
-
$31.00M(-32.6%)
$77.00M(+67.4%)
Mar 2000
-
$46.00M
$46.00M
Dec 1999
$201.00M
-
-

FAQ

  • What is Edwards Lifesciences annual EBITDA?
  • What is the all time high annual EBITDA for Edwards Lifesciences?
  • What is Edwards Lifesciences annual EBITDA year-on-year change?
  • What is Edwards Lifesciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly EBITDA year-on-year change?
  • What is Edwards Lifesciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM EBITDA year-on-year change?

What is Edwards Lifesciences annual EBITDA?

The current annual EBITDA of EW is $1.48B

What is the all time high annual EBITDA for Edwards Lifesciences?

Edwards Lifesciences all-time high annual EBITDA is $1.93B

What is Edwards Lifesciences annual EBITDA year-on-year change?

Over the past year, EW annual EBITDA has changed by -$280.50M (-15.93%)

What is Edwards Lifesciences quarterly EBITDA?

The current quarterly EBITDA of EW is $409.90M

What is the all time high quarterly EBITDA for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly EBITDA is $837.20M

What is Edwards Lifesciences quarterly EBITDA year-on-year change?

Over the past year, EW quarterly EBITDA has changed by -$66.30M (-13.92%)

What is Edwards Lifesciences TTM EBITDA?

The current TTM EBITDA of EW is $1.74B

What is the all time high TTM EBITDA for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM EBITDA is $1.98B

What is Edwards Lifesciences TTM EBITDA year-on-year change?

Over the past year, EW TTM EBITDA has changed by +$140.20M (+8.77%)
On this page